Enfortumab Biosimilar (Nectin-4 Reference Antibody)
Enfortumab is a humanized derived anti-Nectin-4 antibody that can be conjugated with the highly efficient microtubule disruptor MMAE (HY-15162) to generate the antibody drug conjugate (ADC) Enfortumab vedotin (HY-P99016A) . Enfortumab can be used for the study of locally advanced and metastatic urothelial carcinoma.
Product Specifications
Target
Enfortumab Biosimilar (Anti-Nectin-4 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cancer Biology
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
30254116 3x 1.0 µg
Mmp3 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat)
Sign In for Pricing
View Details 
abx141977-01 50 µL
N(Alpha)-Acetyltransferase 50, NatE Catalytic Subunit (NAT13) Antibody
Sign In for Pricing
View Details abx141977-02 100 µL
N(Alpha)-Acetyltransferase 50, NatE Catalytic Subunit (NAT13) Antibody
Sign In for Pricing
View Details abx141977-03 200 µL
N(Alpha)-Acetyltransferase 50, NatE Catalytic Subunit (NAT13) Antibody
Sign In for Pricing
View Details